Sign in
8-K

Current Report

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-13-002945

Agreement ended · Executive or director change

  • Item 1.02 Termination of a material definitive agreement
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading f8k053113_actinium.htm…